Navigation Links
Roche clinical trial registry and results database launched

Within only three months after deciding to create an electronic database, Roche is launching a public clinical trial registry and results database using an independent host, CenterWatch. On www.roche-trials.com information on Roche’s clinical trials can be accessed by anyone, anywhere, with no password restrictions. This site is designed to give patients and healthcare providers ready access to information they need, in terms they can understand.

Ed Holdener, Head of Global Pharma Development at Roche, said: “We are proud to go live with our publicly accessible protocol registry and clinical trial results database today. Transparency has always been and continues to be a priority for us. In January, we announced our plans to have an independent host for the database and since then, we selected CenterWatch, a company with a wealth of experience in the area of data management and the publication of clinical trial information. So for the first time ever, there is now a global and publicly accessible database, containing comprehensive information about Roche’s clinical trials?

Roche expects that the huge task of publishing data from more than 30 medicines, on a product by product level from a large number of global and local trials, will take approximately a year. Roche will also continue to contribute information to established databases (i.e. www.clinicaltrials.gov)

Information that can be found in the electronic database
Starting with Fuzeon and Bondronat, clinical trial information will be added in a staged approach on the databases and will ultimately include protocol information and results from all Phase II to Phase IV clinical trials completed after 1 October, 2004. In addition, data from all Phase II to Phase IV clinical trials for medicines first marketed after 1 October, 2002 will be included retrospectively. The clinical trial registry and results database will also include interventional clinical studies from Roche Diagnostics.<
'"/>

Source:Roche


Page: 1 2 3

Related biology news :

1. Rochester scientists develop fast-working biosensor
2. NIAID begins clinical trial of West Nile virus vaccine
3. Compound might defeat African sleeping sickness, clinical trial beginning this month
4. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
5. Dalai Lama, top scientists to discuss science & clinical applications of meditation
6. Stem cells electric abilities might help their safe clinical use
7. New malaria vaccine shows promise in early clinical trial
8. Preclinical study of a new brain tumor therapy
9. Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
10. Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial
11. NIH announces phase III clinical trial of creatine for Parkinsons disease
Post Your Comments:
(Date:7/3/2008)...on canal would seem a healthier place for toads th...niversity of Florida scientists have found the opp...or a longstanding debate over whether agricultural...sts have found that toads in suburban areas are le...malities than toads near farms where some had bot...
(Date:7/3/2008)...vided vital information to relief workers in Myanm...window following the devastating Cyclone Nargis th...ately after the disaster, the UN Office for the Co...e International Charter on ,Space and Major Disast... providing immediate crisis mapping of the affecte...
(Date:7/3/2008)...hat, eventually, bacteria outsmart them and become... such resistance, a new drug may be able to finall...ested the new drug, called Ceftobiprole, against s...t Staphylococcus aureus (MRSA) bacteria, which are...cal infections worldwide, both in hospitals and in...
(Date:7/2/2008)...the U.K. have discovered that our own body not onl...ngredient in marijuana (THC), but these play an i...inding on "endocannabinoids" just published online...e of, The FASEB Journal could lead to new drugs ...y skin, and even skin-related tumors. , "Our pr...
Breaking Biology News(10 mins):New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3New antibiotic beats superbugs at their own game 2Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference 19271 1Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference 19271 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2057 1Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2057 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2057 3Learning Good Eating Habits Early Leads to Lifelong Health and Wellness 19267 1Learning Good Eating Habits Early Leads to Lifelong Health and Wellness 19267 2Simcere Pharmaceutical Group Announces SFDA Approval of First to Market Generic Biapenem Injection Anxin 19263 1Simcere Pharmaceutical Group Announces SFDA Approval of First to Market Generic Biapenem Injection Anxin 19263 2
...eria monocytogenes invades the body, it commandeer...er cells. In a report published in the Journal of ...e insight into the molecular mechanisms behind thi...he "Paper of the Week" in the March 25 issue of th...iety for Biochemistry and Molecular Biology journa...
...rboreal animals have learned to glide through the ...d frogs, and even ?frightening as it sounds ?snake...t the University of California, Berkeley, and the ...TMB). , Gliding ants ?the only wingless insects k...erved last year outside Iquitos, Peru, by insect e...
...cooperate with each other to promote pediatric cas...is finding, from investigators at St. Jude Childre... issue of Molecular Cell Biology (MCB). , B-cell l...g cells (B lymphocytes) multiply uncontrollably an...chers report that TEL2 cooperates with MYC to incr...
...ing a genetically modified baculovirus and caterpi...ation have been able to speed up a key step in the...za vaccine. They report their findings today at th...e Research Meeting. , "The bird flu may become the...time," says Keyang Wang, a scientist at Protein Sc...
Other Biology News:Scientists discover that host cell lipids facilitate bacterial movement 2Falling ants glide back to trunk to avoid dangers of forest floor 2Falling ants glide back to trunk to avoid dangers of forest floor 3Falling ants glide back to trunk to avoid dangers of forest floor 4Falling ants glide back to trunk to avoid dangers of forest floor 5TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 2TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 3Influenza vaccine uses insect cells to speed development 2
(Date:7/2/2008)...w products coming soon to Bioniche,s growing line ...cts, LAKE FOREST, Ill., July 2 /- Bi...r of injectable pharmaceuticals, announced today,t...ENLON product line,including:, -- ENLON(R) (ed... vial -- ENLON-PLUS(R) (edrophonium chloride, USP...
(Date:7/2/2008)...nnovator develops new therapies based on cells man...d Novo A/S provide funding round, SALT LAKE CITY ...ure,Inc., a biotechnology company at the forefront... acute kidney injury, today announced the closing ... by SV Life Sciences with Novo,A/S joining the syn...
(Date:7/2/2008)...g to Advance Commercialization of Expanded Portfol...ucts, VANCOUVER, British Columbia, July 2 /PRNews...l Ventures Corp. (TSXV: MEV), a company developing...es, today announced its name,change and the expans...eted,the acquisition of two vascular product devel...
(Date:7/1/2008)...ORTH, N.J., July 2 /- Scher...ed the successful closing of its,previously announ... health,products from selected franchises. These d...on as part of its October 2007 clearance of the,ac... Virbac acquired products from the endocrine, mast...
Breaking Biology Technology:Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
...hly-concentrated, opaque, or solid samples such as...polymer films, or phosphors, front-face fluorescen...ntitative and qualitative fluorescence measurement...y have problems with self-absorption and complete ...ce at 90, intensity measurements may not be reprod...
...Samples , 20 L, 50 L, 250 L, or 1 mL <P ,>... amino acids ,<P ,> Maximum Sensitivit...ty <P ,>Samples can be valuable. Either you ...much with which to start. Biological proteins and ...volumes and may be expensive. On the other hand, i...
...SSAYS , The MicroBeta is and ideal instr...on coated microtitration plates. The following met...ssay. The data presented compare the standard immu...red by PerkinElmer Life Sciences. , The b... (1) Coat the wells according to the standard meth...
..., Abnormalities in neurotransmission withi...cluding anxiety, depression or schizophrenia. Exte...e mode of action of various transmitters, in order...cells, binding of the neurotransmitter to its rece... adenosine 3, 5, cyclic monophosphate (cAMP), thr...
Other Biology Technology:Coated Plate Immunoassay on the MicroBeta - eg. TSH - IRMA 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 2In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 3In Vitro Measurement of the Second Messenger cAMP: RIA vs. FlashPlate 4
...ackable multi-function incubator. It uses a microp... accurately control temperature and agitation spee...perature in the incubator. Temperature can be easi...Built in maintenance-free stepping motor for hybri...
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
RNaseZap Wipes from Ambion
Biology Products: